日期:
2020 年 — 2026 年
2020
2021
2022
2023
2024
2025
2026
影响因子:

Effectiveness of ICI-ICI versus ICI-TKI combinations in patients with IMDC intermediate- and poor-risk metastatic renal cell carcinoma: a sub-analysis of the MEET-URO 33 study

在IMDC中危和高危转移性肾细胞癌患者中,ICI-ICI联合方案与ICI-TKI联合方案的疗效比较:MEET-URO 33研究的亚组分析

Maffezzoli, Michele; Signori, Alessio; Acunzo, Alessandro; Buti, Sebastiano; Bosoni, Michela; Verzoni, Elena; Di Marco, Andrea; Lolli, Cristian; Di Napoli, Marilena; Fanelli, Martina; Volta, Alberto Dalla; Masini, Cristina; Roviello, Giandomenico; Iacovelli, Roberto; Mennitto, Alessia; Filippi, Roberto; Sorarù, Mariella; Formisano, Luigi; Guida, Annalisa; Fantinel, Emanuela; Messina, Carlo; Bonomi, Lucia; Scagliarini, Sarah; Nasso, Cecilia; Chiellino, Silvia; Maiorano, Brigida Anna; Deppieri, Filippo; Cavo, Alessia; Conteduca, Vincenza; Zai, Silvia; Zucali, Paolo Andrea; Tucci, Marcello; Vignani, Francesca; La Russa, Francesca; Lombardo, Laura; Caserta, Claudia; Paolieri, Federico; Bertolotti, Francesca; Rescigno, Pasquale; Banna, Giuseppe Luigi; Fornarini, Giuseppe; Bimbatti, Davide; Rebuzzi, Sara Elena

Pazopanib-associated remodeling of platelet-immune cell crosstalk and immune suppressive platelet-derived extracellular vesicles in metastatic RCC

帕唑帕尼相关血小板-免疫细胞相互作用重塑及转移性肾细胞癌中血小板衍生的免疫抑制性细胞外囊泡

Lupoli, Gianpiero; Bergamini, Stefano; Salsetta, Jeannette; Mereu, Alessandro; Cova, Agata; D'Angelo, Elisa; Shahaj, Eriomina; Vergani, Elisabetta; Stroscia, Martina; Di Carlo, Emma; Rivoltini, Licia; Verzoni, Elena; Huber, Veronica

Real-life Use of Cabozantinib in Front-line therapy for Metastatic Renal Cell Carcinoma: The CabFRONT Study (Meet-URO 24)

卡博替尼一线治疗转移性肾细胞癌的真实世界应用:CabFRONT 研究(Meet-URO 24)

Stellato, Marco; Sepe, Pierangela; Bronte, Enrico; Conteduca, Vincenza; Rocca, Maria Cossu; De Giorgi, Ugo; Di Napoli, Marilena; Galli, Luca; Incorvaia, Lorena; Lalli, Luca; Maiorano, Brigida Anna; Maruzzo, Marco; Mennitto, Alessia; Roviello, Giandomenico; Santoni, Matteo; Sorarù, Mariella; Zanardi, Elisa; Zucali, Paolo; Procopio, Giuseppe; Verzoni, Elena

Updated overall survival in patients with prior checkpoint inhibitor therapy in the phase III TIVO-3 study

III期TIVO-3研究中既往接受过免疫检查点抑制剂治疗的患者的总生存期更新

Zugman, Miguel; McDermott, David F; Escudier, Bernard J; Hutson, Thomas E; Porta, Camillo; Verzoni, Elena; Atkins, Michael B; Rini, Brian; Pal, Sumanta K

Leveraging knowledge for explainable AI in personalized cancer treatment: challenges and future directions

利用知识实现可解释人工智能在个性化癌症治疗中的应用:挑战与未来方向

Daghir-Wojtkowiak, Emilia; Alfaro, Javier; Mastromattei, Michele; Palkowski, Aleksander; Stares, Mark; Roca-Umbert, Ana; Krajnc, Andraz; Leoni, Riccardo; Boland, Anne; Nourbaksh, Aria; Kallor, Ashwin; Ducki, Camille; Venditti, Davide; Montesano, Carla; Cipriani, Chiara; Faria, Daniel; Pflieger, Delphine; Zago, Elisa; Bardet, Etienne; Serrano, Filipa; Jeanneret, Florian; Alouges, Damien; Yin, Liangwei; Coquelet, Elodine; Bacquet, Apolline; Bonchi, Francesco; Maiorino, Francesco; Torino, Francesco; Bedran, Georges; Long, Jean-Alexandre; Balbi, Laura; Guyon, Laurent; Bevilacqua, Liana; Fiorelli, Manuel; Wagner, Marie-Catherine; Reyes, Mario; Roselli, Mario; Silva, Marta Contreiras; Waleron, Michal; Dovrolis, Nikolas; Filhol-Cochet, Odile; Um, In Hwa; Wolflein, Georg; Eugénio, Patrícia; Bazelle, Pauline; Golnas, Pavlos; Thorpe, Peter; Bove, Pierluigi; Borole, Piyush; Bernardini, Roberta; Kumar, Rohit; Cicconi, Rosella; Kaltenbrunner, Saskia; Gravina, Saverio; Brezar, Simona; Symeonides, Stefan; McGinn, Steven; Nunes, Susana; Hupp, Ted; Gordienko, Yuri; Varvaras, Dimitrios; Stirenko, Sergii; Xumerle, Luciano; Mariani, Stefania; Bouzit, Assilah; Gazut, Stéphane; Poth, Heiko; Souliotis, Kyriakos; Katifelis, Hector; Verzoni, Elena; Procopio, Giuseppe; Schoch, Sarah; Lupiáñez-Villanueva, Francisco; Türk, Sandra; Barud, Katarzyna; Koroliouk, Dimitri; Caubet, Juan; Moreno, Yamir; Descotes, Jean-Luc; Golna, Christina; Guadalupi, Valentina; Garagnani, Paolo; Gazouli, Maria; Deleuze, Jean-François; Folkvord, Frans; Forgó, Nikolaus; Harrison, David J; Axelson, Håkan; Stellato, Armando; Mattei, Maurizio; Rajan, Ajitha; Laird, Alexander; Battail, Christophe; Pesquita, Catia; Zanzotto, Fabio Massimo

Nivolumab plus relatlimab and nivolumab plus ipilimumab for patients with advanced renal cell carcinoma: results from the open-label, randomised, phase II FRACTION-RCC trial

纳武利尤单抗联合瑞拉利单抗和纳武利尤单抗联合伊匹木单抗治疗晚期肾细胞癌患者:来自开放标签、随机、II期FRACTION-RCC试验的结果

Choueiri, T K; Kuzel, T M; Tykodi, S S; Verzoni, E; Kluger, H; Nair, S; Perets, R; George, S; Gurney, H; Pachynski, R K; Folefac, E; Castonguay, V; Lee, C-H; Vaishampayan, U; Miller, W H Jr; Bhagavatheeswaran, P; Wang, Y; Gupta, S; DeSilva, H; Lee, C-W; Escudier, B; Motzer, R J

A phase II study evaluating the efficacy of enzalutamide and the role of liquid biopsy for evaluation of ARv7 in mCRPC patients with measurable metastases including visceral disease (Excalibur study)

一项 II 期研究评估了恩扎卢胺的疗效以及液体活检在评估伴有可测量转移(包括内脏疾病)的 mCRPC 患者中 ARv7 的作用(Excalibur 研究)。

Sepe, Pierangela; Procopio, Giuseppe; Pircher, Chiara Carlotta; Basso, Umberto; Caffo, Orazio; Cappelletti, Vera; Claps, Melanie; De Giorgi, Ugo; Fratino, Lucia; Guadalupi, Valentina; Miodini, Patrizia; De Marco, Cinzia; Perrucci, Bruno; Mennitto, Alessia; Santini, Daniele; Spina, Francesco; Stellato, Marco; de Braud, Filippo; Verzoni, Elena

Long-Term Survival in Patients With Relapsed/Refractory Advanced Renal Cell Carcinoma Treated With Tivozanib: Analysis of the Phase III TIVO-3 Trial

替沃扎尼治疗复发/难治性晚期肾细胞癌患者的长期生存率:III期TIVO-3试验分析

Beckermann, Kathryn E; Asnis-Alibozek, Aviva G; Atkins, Michael B; Escudier, Bernard; Hutson, Thomas E; Kasturi, Vijay; McDermott, David F; Pal, Sumanta K; Porta, Camillo; Rini, Brian I; Verzoni, Elena

Hematological Toxicity of PARP Inhibitors in Metastatic Prostate Cancer Patients with Mutations of BRCA or HRR Genes: A Systematic Review and Safety Meta-analysis

PARP抑制剂对携带BRCA或HRR基因突变的转移性前列腺癌患者的血液学毒性:系统评价和安全性荟萃分析

Maiorano, Brigida Anna; De Giorgi, Ugo; Verzoni, Elena; Maiello, Evaristo; Procopio, Giuseppe; Conteduca, Vincenza; Di Maio, Massimo

Correction to: Hematological Toxicity of PARP Inhibitors in Metastatic Prostate Cancer Patients with Mutations of BRCA or HRR Genes: A Systematic Review and Safety Meta-analysis

更正:PARP抑制剂对携带BRCA或HRR基因突变的转移性前列腺癌患者的血液学毒性:系统评价和安全性荟萃分析

Maiorano, Brigida Anna; De Giorgi, Ugo; Verzoni, Elena; Maiello, Evaristo; Procopio, Giuseppe; Conteduca, Vincenza; Di Maio, Massimo